skip to Main Content

October is Breast Cancer Awareness Month

Things turn pink in October, from professional sports jerseys to buildings that swap out their traditional lighting for a pink glow. 

This is because October is Breast Cancer Awareness Month. The month-long campaign to bring awareness to breast cancer began in 1985 as a collaboration between the American Cancer Society and the pharmaceutical division of Imperial Chemical Industries (now AstraZeneca). 

Former first lady Betty Ford kicked off the inaugural Breast Cancer Awareness Month. As a breast cancer survivor, she helped bring awareness to the prevalence of this disease during her husband’s presidency.

Today, many breast cancer organizations and activists continue the mission to inform men and women about breast cancer and to raise funds for necessary cancer research.

The Impact of Breast Cancer

Breast cancer is the second deadliest cancer for women, following lung cancer. This cancer tends to affect women as they age, and breast cancer patients have a median age of 62 at the time of diagnosis.

Many people think breast cancer only impacts women, but it also affects thousands of men every year. According to the National Breast Cancer Coalition, the U.S. will see around 281,550 new breast cancer cases in women in 2021 and 2,650 in men. 

Of those diagnosed, an estimated 43,600 women and 530 men will die of breast cancer in 2021. 

Breast Cancer Therapies on the Market

The good news is that many patients are breast cancer survivors, thanks to advances in breast cancer treatment. These treatments include a combination of surgery, chemotherapy, hormone therapy, radiation, and targeted therapies. 


The first and most common way to treat breast cancer is surgery, which involves removing the tumor. There are a few surgical options, depending on the specifics of the patient. These can include a partial mastectomy, radical mastectomy, lumpectomy, and reconstruction. In some cases, the surgeon may also remove the lymph nodes to evaluate how the cancer is spreading throughout the body.


Most breast cancer patients will also go through chemotherapy, which administers a combination of drugs throughout the entire body. These drugs will either destroy cancer cells or slow their growth. In addition, chemotherapy sometimes happens before surgery to shrink the size of the tumor. 


Radiation can target any cancerous cells that are left after surgery. It is highly targeted and only affects the specific area receiving radiation.

Hormone therapy

The hormones estrogen and progesterone can sometimes cause cancer to grow. As a result, doctors may prescribe hormone blockers or hormone inhibitors for patients with breast cancer positive for hormone receptors. These medications are often taken at the same time the patient is going through chemotherapy. 

Tamoxifen is the most commonly prescribed hormone blocker. It can be taken daily for up to five years after surgery. It is sometimes taken to prevent breast cancer in women who are at an elevated risk.

Toremifene is another daily pill that can treat breast cancer that has spread to other parts of the body. It is usually prescribed to postmenopausal women.

Fulvestrant is administered as a shot and is used to treat advanced breast cancer. In the first month, women will receive a dose every two weeks. After that, they will get one shot a month.

Breast Cancer Awareness Offer from Healthlink Dimensions 

Wearing pink can help bring awareness to this serious disease, but, unfortunately, it will not cure it or prevent it. Patients need access to doctors and specialists to help them identify warning signs and risk factors for breast cancer. 

Speak to a Representative

Offer from HealthLink Dimensions

As a result of Breast Cancer Awareness Month’s media campaigns and activities, many more men and women will make appointments with oncologists and OB-GYNs. Therefore, Healthlink Dimensions has created a special program for lifescience, health insurer, and hospitals wishing to promote public service announcement (PSA) content to healthcare providers.

HealthLink Dimensions has created a custom programmatic segment targeting oncologists and OB/GYNs named “Breast Cancer Awareness” and available in LiveRamp. We have also reduced the cost for this programmatic segment price from $15.50 CPM to $5CPM through Nov 30, 2021, for PSA usage. All HealthLink Dimensions proceeds will be donated to the Susan G Komen foundation to fund breast cancer research. Search for “HealthLink Dimensions Breast Cancer Awareness” in LiveRamp today and get started.

For those wishing to specifically identify physicians actively treating breast cancer, HealthLink Dimensions’ Treatment Insights highlight the most valuable Oncologists and other specialists involved in the care and treatment of breast cancer patients. An analysis of ICD-10 and Rx data reveals that HealthLink Dimensions has over 12,800 verified email addresses for Oncologists who have treated Breast Cancer in addition to many more nurse practitioners and physician assistants who are likely influential in the patient’s journey.

To learn more about Treatment Insights and how HealthLink Dimensions segments high-value healthcare providers within a particular diagnostic or therapeutic class, fill out the form or chat with us today.

Back To Top